"The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of selexipag (Uptravi, Actelion Registration Ltd) for the treatment of adults with pulmonary arterial hypertension (PAH)./"...
(Generic versions may still be available.)
TIMOLIDE (timolol maleate-hydrochlorothiazide) is indicated for the treatment of hypertension.
This fixed combination drug is not indicated for initial therapy of hypertension. If the fixed combination represents the dose titrated to an individual patient†s needs, it may be more convenient than the separate components.
DOSAGE AND ADMINISTRATION
The recommended starting and maintenance dosage is 1 tablet twice a day or 2 tablets once a day. Hydrochlorothia-zide can be given at doses of 12.5 to 50 mg per day when used alone. If the antihypertensive response is not satisfactory, another nondiuretic antihypertensive agent may be added.
No. 3373 _ Tablets TIMOLIDE (timolol maleate-hydrochlorothiazide) 10-25 are light blue, flat, hexagonal-shaped, compressed tablets, with code MSD 67 on one side and TIMOLIDE (timolol maleate-hydrochlorothiazide) on the other. Each tablet contains 10 mg of timolol maleate and 25 mg of hydrochlorothiazide. They are supplied as follows: NDC 0006-0067-68 bottles of 100.
Store at controlled room temperature, 15-30°C (59-86°F). Keep container tightly closed. Protect from light.
Whitehouse Station, NJ 08889, USA
Issued October 2003This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/28/2005
Additional Timolide Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on handling your hypertension.